Back to libraryBone Health

Abaloparatide

Research profile · How we handle evidence

Abaloparatide is a synthetic peptide related to parathyroid hormone-related protein (PTHrP). It is approved for certain patients with osteoporosis and is designed to stimulate new bone formation and improve bone density.

Evidence Score

68/100

High confidence

Category

Bone Health

Therapeutic area

Standard Dose

80mcg daily

Daily

Half-life

~1 hr

Plasma elimination

Route

SC

Subcutaneous

Safety Tier

3

Limited data

Overview

Think of abaloparatide as a medication that encourages the body to build new bone. Researchers and clinicians use it to help reduce fracture risk in people with severe osteoporosis, but results vary between individuals.

Mechanism of Action

Think of abaloparatide as a medication that encourages the body to build new bone. Researchers and clinicians use it to help reduce fracture risk in people with severe osteoporosis, but results vary between individuals.

Bone HealthWellness

pH & Mixing

5.1-5.2

Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.

A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.

Benefits

  • Increased bone density
  • Bone formation stimulation
  • Fracture risk reduction
  • Osteoporosis treatment

Side Effects

  • Dizziness
  • Nausea
  • Headache
  • Elevated calcium levels in some patients

Contraindications

  • Pregnancy
  • Bone cancer
  • Hypercalcemia
  • Paget's disease

Structure & Sequence

View 3D structure

Verified structure

Abaloparatide

Sequence illustration backed by PubChem match.

Verified via PubChemMatched by name
C174H300N56O493,961 Da34 residues
Source: PubChemLookup: AbaloparatideInChIKey BVISQZFBLRSESR-XSCWXTNMSA-N
Amino Acid Sequence
AVSEHQLLHDKGKSIQDLRRRELLEKLL-Aib-KLHTA-NH2 (34aa, PTHrP analog)
Molecular Weight
3,961 Da
Chemical Formula
C174H300N56O49
CAS Number
N/A
Reconstituted pH
5.1-5.2
InChIKey
BVISQZFBLRSESR-XSCWXTNMSA-N

Stack & Route Context

Stacks with

  • Teriparatide

Administration

Subcutaneous

Research Status

FDA approved for osteoporosis treatment.

Approval Status

Approved

Sports Legal

Restricted

References

No references listed.

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.